Codiak BioSciences, Inc. — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d8ca49ff-be30-413e-9d1d-5027b7f21a17/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-69.5M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-003373 |
| FY 2020 | $-90.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013870 |
| FY 2019 | $-80.2M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-013870 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).